Somatostatin receptor — Drug Target

All drugs that target Somatostatin receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Somatostatin analogue · somatostatin analog · Somatostatin receptor targeting agent

Phase 3 pipeline (2)

• Placebo lanreotide · University Hospital, Limoges · Somatostatin analogue · Endocrinology
  Lanreotide is a somatostatin analogue that inhibits the release of growth hormone and other hormones.
• octreotide capsules · Chiasma, Inc. · somatostatin analog · Endocrinology
  Octreotide capsules mimic the natural hormone somatostatin to decrease production of growth hormone and other hormones.

Phase 2 pipeline (1)

• 64Cu-DOTA-AE105 · Curasight · Somatostatin receptor targeting agent · Oncology
  Somatostatin receptor targeting

Phase 1 pipeline (4)

• 131I-IPA · Telix Pharmaceuticals (Innovations) Pty Limited · Somatostatin receptor targeting agent · Oncology
  Iodine-131 labelled peptide for targeted radionuclide therapy
• 64Cu-DOTA-TLX592 · Telix Pharmaceuticals (Innovations) Pty Limited · Somatostatin receptor targeting agent · Oncology
  Somatostatin receptor targeting
• 153Sm-DOTMP · Telix Pharmaceuticals (Innovations) Pty Limited · Somatostatin receptor targeting agent · Oncology
  A radioligand targeting somatostatin receptors
• 177Lu-DOTA-EB-TATE · Molecular Targeting Technologies, Inc. · Somatostatin receptor targeting agent · Oncology
  Somatostatin receptor targeting